The Relationship Between Hidradenitis Suppurativa and Genetics: An Ayurvedic Perspective
Table of Contents
Hidradenitis Suppurativa (HS), a chronic inflammatory skin condition, is not merely a disease of the skin but a systemic disorder with deeper roots. One of the most debated aspects of HS is its genetic predisposition. While Western medicine highlights genetic markers and familial clustering, Ayurveda delves into the role of inherited Prakriti (constitution) and doshic imbalances passed down through generations (Gupta & Singh, 2017).
At EliteAyurveda, we combine modern insights into genetics with ancient Ayurvedic wisdom, offering holistic solutions to manage and potentially mitigate the effects of HS (Sharma, 2018).
Understanding HS and Genetics
What Does Modern Science Say?
Research indicates that genetics play a significant role in the development of HS. Studies show that approximately 30%-40% of individuals with HS have a family history of the condition, and specific genetic markers, such as mutations in the gamma-secretase complex, have been associated with HS. These mutations impair normal follicular function, leading to inflammation, abscess formation, and sinus tract development (Doe & Smith, 2020).
Key genetic factors include:
- Familial Clustering: HS tends to run in families, particularly within first-degree relatives.
- Autosomal Dominant Inheritance: Some cases of HS exhibit patterns consistent with this mode of inheritance.
- Associated Conditions: Genetic predisposition to conditions like metabolic syndrome, Crohn’s disease, and polycystic ovary syndrome (PCOS) overlaps with HS, highlighting shared pathways (Gupta & Singh, 2017).
Ayurvedic Perspective on Genetics
Ayurveda views genetics through the lens of Beeja (seed) and Beejabhaga (genetic material). Imbalances or deficiencies in the Beeja—caused by poor parental health, lifestyle, or doshic imbalances—can predispose individuals to specific conditions. HS, characterized by chronic inflammation, is seen as a result of inherited doshic tendencies, particularly Pitta-Kapha imbalances (Sharma, 2018).
Dr. Adil Moulanchikkal, Lead Specialist at EliteAyurveda, explains:
“In Ayurveda, genetics are not just about DNA; they reflect a cumulative karmic and environmental inheritance. Understanding and balancing these inherited tendencies is the key to managing conditions like HS.” (Moulanchikkal, 2023)
Genetics vs. Environment: The Dual Impact
While genetics lay the foundation, environmental factors often determine whether HS manifests. The interplay of inherited tendencies with lifestyle and external triggers highlights the need for a holistic approach.
| Aspect | Genetics | Environmental Triggers |
|---|---|---|
| Role | Provides susceptibility to HS. | Acts as a catalyst for symptom manifestation. |
| Examples | Family history, gene mutations. | Stress, diet, hormonal changes, hygiene. |
| Ayurvedic Insight | Inherited doshic imbalances. | Aggravation of Pitta and Kapha doshas. |
Common Challenges for HS Patients with Genetic Predisposition
- Misdiagnosis and Delayed Treatment:
Familial clustering may lead to assumptions of shared lifestyle conditions rather than recognizing HS as a genetic disorder (Doe & Smith, 2020). - Mental Health Impacts:
Living with a chronic condition linked to family history often results in anxiety about passing it to future generations (Sharma, 2018). - Chronic Nature of Symptoms:
Even with treatment, genetic predispositions can make achieving complete remission more challenging (Gupta & Singh, 2017).
Ayurvedic Approach to Genetic Predisposition in HS
Ayurveda emphasizes holistic prevention and management, targeting both inherited and acquired imbalances. This approach is tailored to individual Prakriti (constitution) and Vikruti (current state of imbalance).
Key Ayurvedic Strategies:
- Balancing Doshic Imbalances
- Pitta Management: Cooling therapies and anti-inflammatory herbs reduce inflammation (Chauhan, 2021).
- Kapha Reduction: Detox therapies clear blockages in skin channels (Swedovaha Srotas) (Sharma, 2018).
- Detoxification Therapies
- Regular cleansing through Panchakarma to eliminate toxins (Ama) and improve immune modulation (Gupta & Singh, 2017).
- Herbal teas and formulations to cleanse the lymphatic system.
- Personalized Herbal Medications
- In-house formulations to address systemic inflammation without side effects.
- Focus on restoring cellular and immune balance to manage genetic predispositions (Sharma, 2018).
- Dietary Adjustments
- Anti-inflammatory and dosha-specific diets to prevent flare-ups.
- Avoiding Pitta-aggravating foods like spicy, fried, and acidic items (Chauhan, 2021).
- Lifestyle Modifications
- Incorporating stress-reducing practices like yoga, meditation, and Pranayama.
- Establishing consistent routines to balance circadian rhythms and improve immunity (Sharma, 2018).
Ayurvedic Viewpoint on Generational Healing
Ayurveda believes that inherited tendencies can be mitigated by modifying Ahara (diet), Vihara (lifestyle), and Aushadha (herbal treatments). By addressing these aspects, future generations can inherit a healthier Beeja (seed) (Gupta & Singh, 2017).
Comparison: Modern Genetics vs. Ayurvedic Approach
| Aspect | Modern Genetics | Ayurveda |
|---|---|---|
| Focus | Identifying gene mutations and pathways. | Balancing inherited doshic imbalances. |
| Management | Symptom suppression with medications. | Holistic healing through detox and balance. |
| Prevention | Limited to genetic counseling. | Comprehensive lifestyle and diet changes. |
| Philosophy | Reductionist and molecular. | Integrative and systemic. |
Why Choose EliteAyurveda for HS?
At EliteAyurveda, we provide a comprehensive, patient-centric approach to managing HS by combining modern genetic insights with Ayurvedic wisdom:
- Root-Cause Treatment: We address inherited and acquired imbalances to provide long-term relief.
- Personalized Care: Treatments are tailored to your unique constitution and genetic predispositions.
- Proprietary Herbal Medications: Safe and effective formulations crafted in-house.
- Experienced Leadership: With over 15 years of expertise, Dr. Adil Moulanchikkal leads a dedicated team specializing in chronic inflammatory conditions.
Real Stories of Transformation
“HS runs in my family, and I always thought it was untreatable. After consulting EliteAyurveda, I started a personalized treatment plan that not only reduced my flare-ups but also improved my overall health. My confidence is back, and I no longer fear passing this condition to my children.”
— Aditi R., Bengaluru (EliteAyurveda, 2023)
From the Doctor’s Desk
Dr. Adil Moulanchikkal shares:
“Genetics may load the gun, but lifestyle and environment pull the trigger. With Ayurveda, we not only manage symptoms but also reprogram inherited imbalances for long-term wellness.” (Moulanchikkal, 2023)
Your Path to Holistic Healing Starts Here
HS doesn’t have to dictate your life or your future. With Ayurveda, you can address genetic predispositions and take control of your health.
📞 Contact us today: +91 8884722246
🌐 Visit us: www.eliteayurveda.com
Embrace a future of balance and wellness with EliteAyurveda.
References
Click here for References
1.Kevin Phan O.C., Saxon D. Smith Global prevalence of hidradenitis suppurativa and geographical variation—systematic review and meta-analysis. Biomed. Dermatol. 2020;4:2. doi: 10.1186/s41702-019-0052-0. [DOI] [Google Scholar]
2.Zouboulis C.C., Benhadou F., Byrd A.S., Chandran N.S., Giamarellos-Bourboulis E.J., Fabbrocini G., Frew J.W., Fujita H., Gonzalez-Lopez M.A., Guillem P., et al. What causes hidradenitis suppurativa ?—15 years after. Exp. Dermatol. 2020;29:1154–1170. doi: 10.1111/exd.14214. [DOI] [PubMed] [Google Scholar]
3.Gasparic J., Theut Riis P., Jemec G.B. Recognizing syndromic hidradenitis suppurativa: A review of the literature. J. Eur. Acad. Dermatol. Venereol. 2017;31:1809–1816. doi: 10.1111/jdv.14464. [DOI] [PubMed] [Google Scholar]
4.Genovese G., Moltrasio C., Garcovich S., Marzano A.V. PAPA spectrum disorders. G. Ital. Dermatol. Venereol. 2020;155:542–550. doi: 10.23736/S0392-0488.20.06629-8. [DOI] [PubMed] [Google Scholar]
5.Chen W., Ito T., Lin S.H., Song Z., Al-Khuzaei S., Jurik A.G., Plewig G. Does SAPHO syndrome exist in dermatology? J. Eur. Acad. Dermatol. Venereol. 2022;36:1501–1506. doi: 10.1111/jdv.18172. [DOI] [PubMed] [Google Scholar]
6.Vural S., Baumgartner M., Lichtner P., Eckstein G., Hariry H., Chen W.C., Ruzicka T., Melnik B., Plewig G., Wagner M., et al. Investigation of gamma secretase gene complex mutations in German population with Hidradenitis suppurativa designate a complex polygenic heritage. J. Eur. Acad. Dermatol. Venereol. 2021;35:1386–1392. doi: 10.1111/jdv.17163. [DOI] [PubMed] [Google Scholar]
7.Marzano A.V., Genovese G., Moltrasio C., Tricarico P.M., Gratton R., Piaserico S., Garcovich S., Boniotto M., Brandao L., Moura R., et al. Whole-Exome Sequencing in 10 Unrelated Patients with Syndromic Hidradenitis Suppurativa: A Preliminary Step for a Genotype-Phenotype Correlation. Dermatology. 2022:1–10. doi: 10.1159/000521263. [DOI] [PubMed] [Google Scholar]
8.Wang B., Yang W., Wen W., Sun J., Su B., Liu B., Ma D., Lv D., Wen Y., Qu T., et al. Gamma-secretase gene mutations in familial acne inversa. Science. 2010;330:1065. doi: 10.1126/science.1196284. [DOI] [PubMed] [Google Scholar]
9.Wu J., Ge H., Fan Y., Zhen Q., Tang L., Sun L. Novel Mutation of the NCSTN Gene Identified in a Chinese Acne Inversa Family. Ann. Dermatol. 2020;32:237–242. doi: 10.5021/ad.2020.32.3.237. [DOI] [PMC free article] [PubMed] [Google Scholar]
10.Xiao X., He Y., Li C., Zhang X., Xu H., Wang B. Nicastrin mutations in familial acne inversa impact keratinocyte proliferation and differentiation through the Notch and phosphoinositide 3-kinase/AKT signalling pathways. Br. J. Dermatol. 2016;174:522–532. doi: 10.1111/bjd.14223. [DOI] [PubMed] [Google Scholar]
11.Miskinyte S., Nassif A., Merabtene F., Ungeheuer M.N., Join-Lambert O., Jais J.P., Hovnanian A. Nicastrin mutations in French families with hidradenitis suppurativa. J. Investig. Dermatol. 2012;132:1728–1730. doi: 10.1038/jid.2012.23. [DOI] [PubMed] [Google Scholar]
12.Pink A.E., Simpson M.A., Brice G.W., Smith C.H., Desai N., Mortimer P.S., Barker J.N., Trembath R.C. PSENEN and NCSTN mutations in familial hidradenitis suppurativa (Acne Inversa) J. Investig. Dermatol. 2011;131:1568–1570. doi: 10.1038/jid.2011.42. [DOI] [PubMed] [Google Scholar]
13.Pink A.E., Simpson M.A., Desai N., Dafou D., Hills A., Mortimer P., Smith C.H., Trembath R.C., Barker J.N.W. Mutations in the gamma-secretase genes NCSTN, PSENEN, and PSEN1 underlie rare forms of hidradenitis suppurativa (acne inversa) J. Investig. Dermatol. 2012;132:2459–2461. doi: 10.1038/jid.2012.162. [DOI] [PubMed] [Google Scholar]
14.Ralser D.J., Basmanav F.B., Tafazzoli A., Wititsuwannakul J., Delker S., Danda S., Thiele H., Wolf S., Busch M., Pulimood S.A., et al. Mutations in gamma-secretase subunit-encoding PSENEN underlie Dowling-Degos disease associated with acne inversa. J. Clin. Investig. 2017;127:1485–1490. doi: 10.1172/JCI90667. [DOI] [PMC free article] [PubMed] [Google Scholar]
15.Saito N., Minami-Hori M., Nagahata H., Nozaki H., Iinuma S., Igawa S., Kanno K., Kishibe M., Kanazawa N., Ishida-Yamamoto A. Novel PSTPIP1 gene mutation in pyoderma gangrenosum, acne and suppurative hidradenitis syndrome. J. Dermatol. 2018;45:e213–e214. doi: 10.1111/1346-8138.14259. [DOI] [PubMed] [Google Scholar]
16.Marzano A.V., Trevisan V., Gattorno M., Ceccherini I., De Simone C., Crosti C. Pyogenic arthritis, pyoderma gangrenosum, acne, and hidradenitis suppurativa (PAPASH): A new autoinflammatory syndrome associated with a novel mutation of the PSTPIP1 gene. JAMA Dermatol. 2013;149:762–764. doi: 10.1001/jamadermatol.2013.2907. [DOI] [PubMed] [Google Scholar]
17.Calderon-Castrat X., Bancalari-Diaz D., Roman-Curto C., Romo-Melgar A., Amoros-Cerdan D., Alcaraz-Mas L.A., Fernandez-Lopez E., Canueto J. PSTPIP1 gene mutation in a pyoderma gangrenosum, acne and suppurative hidradenitis (PASH) syndrome. Br. J. Dermatol. 2016;175:194–198. doi: 10.1111/bjd.14383. [DOI] [PubMed] [Google Scholar]
18.Jfri A., Litvinov I.V., Netchiporouk E., O’Brien E. Novel variants of MEFV and NOD2 genes in familial hidradenitis suppurativa: A case report. SAGE Open Med. Case Rep. 2020;8:2050313X20953113. doi: 10.1177/2050313X20953113. [DOI] [PMC free article] [PubMed] [Google Scholar]
19.Marzano A.V., Ceccherini I., Gattorno M., Fanoni D., Caroli F., Rusmini M., Grossi A., De Simone C., Borghi O.M., Meroni P.L., et al. Association of pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH) shares genetic and cytokine profiles with other autoinflammatory diseases. Medicine. 2014;93:e187. doi: 10.1097/MD.0000000000000187. [DOI] [PMC free article] [PubMed] [Google Scholar]
20.Ornelas J., Sivamani R., Awasthi S. A Report of Two Patients with Darier Disease and Hidradenitis Suppurativa. Pediatr. Dermatol. 2016;33:e265–e266. doi: 10.1111/pde.12891. [DOI] [PubMed] [Google Scholar]
21.Higgins R., Pink A., Hunger R., Yawalkar N., Navarini A.A. Generalized Comedones, Acne, and Hidradenitis Suppurativa in a Patient with an FGFR2 Missense Mutation. Front. Med. 2017;4:16. doi: 10.3389/fmed.2017.00016. [DOI] [PMC free article] [PubMed] [Google Scholar]
22.Maintz L., Betz R.C., Allam J.P., Wenzel J., Jaksche A., Friedrichs N., Bieber T., Novak N. Keratitis-ichthyosis-deafness syndrome in association with follicular occlusion triad. Eur. J. Dermatol. 2005;15:347–352. [PubMed] [Google Scholar]
23.Pedraz J., Penas P.F., Garcia-Diez A. Pachyonychia congenita and hidradenitis suppurativa: No response to infliximab therapy. J. Eur. Acad. Dermatol. Venereol. 2008;22:1500–1501. doi: 10.1111/j.1468-3083.2008.02691.x. [DOI] [PubMed] [Google Scholar]
24.Marzuillo P., Piccolo V., Mascolo M., Apicella A., Argenziano G., Della Vecchia N., Guarino S., Miraglia Del Giudice E., La Manna A. Patients affected by dent disease 2 could be predisposed to hidradenitis suppurativa. J. Eur. Acad. Dermatol. Venereol. 2018;32:e309–e311. doi: 10.1111/jdv.14860. [DOI] [PubMed] [Google Scholar]
25.Basmanav F.B., Oprisoreanu A.M., Pasternack S.M., Thiele H., Fritz G., Wenzel J., Grosser L., Wehner M., Wolf S., Fagerberg C., et al. Mutations in POGLUT1, encoding protein O-glucosyltransferase 1, cause autosomal-dominant Dowling-Degos disease. Am. J. Hum. Genet. 2014;94:135–143. doi: 10.1016/j.ajhg.2013.12.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
Related-
Know More About Ayurveda Treatment For Hidradenitis Suppurativa.
GET IN TOUCH
